MedPath

ulipristal acetate in the management of fibroid uterus

Not Applicable
Conditions
Health Condition 1: N858- Other specified noninflammatory disorders of uterus
Registration Number
CTRI/2020/03/024325
Lead Sponsor
sangam jha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Reproductive and premenopausal women (18-50 years age group)

•Symptomatic fibroid (heavy menstrual bleed, pain abdomen, pressure symptoms and infertility)

•Uterine fibroids >=1 in number and size of >= 2cm and <= 10cm on pelvic ultrasound

Exclusion Criteria

•Patients refusing medical management

•Patients with HMB due to causes other than fibroids

•Patients with clinical jaundice or deranged liver function tests

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath